ARCHIVES

Advisors Reaffirm Survival As Standard For full FDA Approval Of Cancer Drugs

This article is from The Cancer Letter archive.

Vol. 25 No. 24 | June 16, 1999

Download PDF Visit The Full Archive

Related Articles

Matrisian, Nelson, to lead review of NCI translational research programs.

September 23, 2005

Tumors Harder To Detect In Women In Their Forties

August 27, 2010

In Brief: Cancer Research Institute to Support AIDS Grants, With Maximum $70,000 Each; Deadline Is Oct. 1

July 15, 1983

Elderly Patients Fail To Receive New Cancer Therapy For CML

August 27, 2010

Clearinghouse Insists On New Dichlorvos Test; CSWG Disagrees

March 24, 1978

Radiation To Stem Cell Niche Improved PFS In Glioblastoma

August 27, 2010